Skip to main content
. 2022 Aug 4;12:985470. doi: 10.3389/fonc.2022.985470

Figure 5.

Figure 5

Low miR-625 levels are associated with the malignant progression of endometrial cancer. (A) The miRNAs that might bind to circ_0007534 were predicted using the CircInteractome database. (B) The luciferase reporter plasmids contained wild-type (WT) and mutated (MUT) miR-625 binding sites in the circ_0007534 sequence. (C) Real-time PCR detection of miR-625 expression in endometrial cancer and normal tissues. (D-G) MiR-625 expression in endometrial cancer patients with different tumor grades (D), tumor stage (E), depth of invasion (F), and the presence (or absence) of lymph node metastasis (G) were explored using qRT-PCRs. (H) MiR-625 expression in endometrial cancer cells and normal cells. ***P < 0.001.